281 results
8-K
EX-99.1
PRPO
Precipio Inc
6 Jan 12
Transgenomic Announces $3 Million Convertible Note Financing
12:00am
Certain statements in this press release constitute “forward-looking statements” of Transgenomic within the meaning of the Private Securities Litigation … in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press
8-K
EX-99.1
PRPO
Precipio Inc
22 Feb 06
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
of the Private Securities Litigation Reform
Act of 1995, which involve known and unknown risks, uncertainties and other
factors that may cause our actual results … for forward-looking statements contained in the Private Securities
Litigation Reform Act of 1995 with respect to all statements contained
8-K
EX-99.1
PRPO
Precipio Inc
18 Mar 05
Entry into a Material Definitive Agreement
12:00am
Securities
Litigation Reform Act of 1995, which involve known and unknown risks,
uncertainties and other factors that may cause our actual results … of the safe harbor for
forward-looking statements contained in the Private Securities Litigation Reform
Act of 1995 with respect to all statements contained
8-K
EX-99.1
PRPO
Precipio Inc
26 May 09
Transgenomic, Inc. Announces Appointment of New Board Members
12:00am
of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause actual … contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release.
8-K
EX-99.1
PRPO
Precipio Inc
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
” of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors … Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release is as of the date
8-K
EX-99.2
d8gcbdn9ocy
14 Jan 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ftb4m5l
4 Jan 11
Transgenomic Announces Closing of the Acquisition of Clinical Data’s Diagnostic Business and the Closing of a $6 Million Financing
12:00am
8-K
EX-99.1
npj9 an3rcc0s
1 Feb 06
Other Events
12:00am
8-K
EX-99.1
ufpnxa7zfg3zotjorvp
26 May 09
Transgenomic, Inc. Announces Appointment of New Board Members
12:00am
8-K
EX-99.1
nvkdy
5 Feb 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-99.1
ov5u5 gucw7s
13 Mar 13
Transgenomic Secures $8.0 Million Credit Facility
12:00am
8-K
EX-99.1
why2tnio4fx
17 Sep 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
9hfs bvmjnusdj
5 Mar 07
Departure of Directors or Principal Officers
12:00am
8-K
EX-99.1
crfu5b
2 Jul 14
Selective Monetization of Research Market Assets Reflects Strategic Focus on Higher Growth olecular Diagnostics and Personalized Medicine Sectors
12:00am
8-K
EX-99
ixgv3pv3t2n
31 Oct 05
Unregistered Sales of Equity Securities
12:00am
8-K
EX-99.1
uy986wi so4f8e
22 Oct 14
Transgenomic Announces $2.375 Million Private Placement Financing
12:00am
8-K
EX-99.1
lnp6kpruq62krajx7xo
15 Nov 06
Departure of Directors or Principal Officers
12:00am
8-K
EX-99.1
8z9g9of3s7kx69 g9rc
27 Sep 12
Transgenomic Completes Acquisition of ScoliScore™ Prognostic Scoliosis Test
12:00am
8-K
EX-99.1
t07up6a6khymv5k7ctpe
30 Sep 13
Transgenomic Announces Executive Changes
12:00am